• by Richard Whitman , Columnist, January 31, 2022

WPP has appointed Simon Dingemans to its Board as a Non-Executive Director. He will serve on the board’s executive committee.

Dingemans is a senior advisor at global investment firm The Carlyle Group with a focus on the healthcare sector, as well as investment opportunities in the UK. (The company is not a major investor in WPP at this time.)

Prior to joining Carlyle, Dingemans was Chief Financial Officer of GlaxoSmithKline and a member of the main board from 2011 to 2019. He is credited with driving extensive cost-saving restructuring and change programs at the company.

Prior to GSK, Dingemans worked in investment banking for 25 years at SG Warburg and then Goldman Sachs, where he was Managing Director and Partner for 10 years and led its European M&A business and Head of UK Investment Banking.

WPP Chairman Roberto Quarta said Dingemans’ addition “will be invaluable to the Board as WPP continues its transformation and strategic progress.”